Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · IEX Real-Time Price · USD
5.96
-0.31 (-4.94%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $228.74 million as of July 2, 2024. Its market cap has increased by 112.58% in one year.
Market Cap
228.74M
Enterprise Value
46.66M
1-Year Change
112.58%
Ranking
Category
Stock Price
$5.96
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $228.74M, a decrease of -69.67%. That is a compound annual growth rate of -16.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 240.60M | 94.19% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atai Life Sciences | 222.65M |
| Greenwich LifeSciences | 222.31M |
| Rezolute | 220.96M |
| Actinium Pharmaceuticals | 220.40M |
| Codexis | 218.73M |
| uniQure | 217.50M |
| NeuroPace | 217.49M |
| Century Therapeutics | 215.48M |